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Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life M W Elliott, A K Simonds, M P Carroll, J A Wedzicha, M A Branthwaite Abstract Background Domiciliary assisted ventilation, using negative or positive pressure devices, is an effective treatment for respiratory failure due to chest wail deformity and neuromuscular disease. Negative pressure ventilators have been used with some success in patients with chronic obstructive lung disease in hospital, but attempts to continue treatment at home have been disappointing. This study evaluates the practicalities of nasal intermittent positive pressure ventilation at home in patients with chronic obstructive lung disease and the effect on sleep and quality of life. Methods and results Twelve patients with chronic obstructive lung disease and hypercapnic respiratory failure received nasal intermittent positive pressure ventilation at home during sleep. At six months eight were continuing with the ventilation. One patient had died and three had withdrawn because they were unable to sleep with the equipment. Full polysomnography performed during ventilation in patients continuing treatment at six months showed an increase in mean PaO2 of 11% (+2% to +23%) and lower mean transcutaneous carbon dioxide tensions (by -2-7 (-1-3 to -5S1) kPa) overnight compared with spontaneous breathing before the start of nasal intermittent positive pressure ventilation. Total sleep time and sleep efficiency changed during ventilation by + 72 5 (+ 21 to +204) mnutesand +5% (-3% to +30%) respectively; sleep architecture and the number of arousals were unchanged. Quality of life did not change but was no worse during ventilation. At one year seven patients were still using the ventilator and Paco2 and bicarbonate ion concentration during the day had improved further by comparison with the values at six months (change from baseline -1-7 (-2-1 to -0-6) kPa, p < 0-05, and -6-3 (-119 to -4) mmolIl, p < 005). Conclusions Nasal intermittent positive pressure ventilation can be used effectively at home during sleep in selected patients with chronic obstructive lung disease. Its future place in management can be established only by formal comparison with long term oxygen therapy.
Nasal intermittent positive pressure ventilation is becoming increasingly recognised as an effective method of supporting patients with respiratory failure due to neuromuscular disease, chest wall deformity, and to a lesser extent chronic obstructive lung disease.`3 It requires no cumbersome external equipment, maintains the patency of the upper airway, and has been used effectively at home overnight.
We have previously reported improved daytime arterial blood gas tensions during spontaneous breathing by day after six months in patients using nasal intermittent positive pressure ventilation regularly at night. 4 The possible mechanisms of these improvements were discussed. In this paper we have looked at the feasibility of domiciliary nasal intermittent positive pressure ventilation overnight in patients with chronic obstructive lung disease, the extent to which nocturnal hypoventilation is controlled, and the resulting effect on sleep and quality of life. Follow up has been continued for one year and arterial blood gas tensions at the end of the study are reported.
Methods

PATIENTS
The study was approved by the ethics committee of the Royal Brompton and National Heart Hospital, and all patients gave informed consent.
Nine male and three female patients with severe stable chronic obstructive lung disease were equipped with domiciliary ventilators. Their clinical details are given in table 1. All had severe airflow limitation and were hypoxaemic and hypercapnic at the time of recruitment. All had past or present peripheral oedema and therefore met the criteria for domiciliary oxygen therapy. Nine patients were recruited from outpatient clinics and their clinical stability was confirmed by a variation of less than 5% in arterial blood gas tensions and forced expiratory volume in one second (FEVI) at the beginning and end of a four week run in period. One patient (case 7) was first seen as an inpatient but did not start nasal intermittent positive pressure ventilation until six weeks after discharge.
The two other patients (cases 8 and I 1) had a long history of progressive deterioration despite maximum conventional treatment, including oxygen, and had been referred with severe adjusted to the patients' comfort and to maximise gas exchange. The patients in cases 1-4 were equipped with the ventilator, instructed in its use, and discharged on the same day. Three out offour had difficulty acclimatising to the technique so subsequent patients remained in hospital until they were confident in using the equipment. This entailed a median stay in hospital of three (range 2 to 10) days. Patients were readmitted after four weeks of using the ventilator at home for overnight monitoring of oxygen saturation (Sao2) and transcutaneous CO2 (Ptcco2); small adjustments were made to ventilator settings if necessary.
PROTOCOL
Arterial blood gas tensions and quality of life were measured before the start of nasal intermittent positive pressure ventilation and after six months of home use in all patients. In addition full polysomnography was performed before the start of nasal intermittent positive pressure ventilation and was repeated during ventilation after six months in patients still using the equipment. Arterial blood gas tensions were measured again after one year. 3 ) and one after five months (case 10). All three had had relatively undisturbed sleep before starting nasal intermittent positive pressure ventilation-two of them while using oxygen at home (cases 2 and 3)-but were unable to sleep so well with the ventilator. They had less airflow obstruction (table 1) and less hypercapnia (fig 1) than the patients who continued domiciliary nasal intermittent positive pressure ventilation. The ventilator was withdrawn from one patient (case 4), whose compliance was poor, after nine months because of worsening cor pulmonale; he was transferred to domiciliary oxygen therapy but continued to deteriorate and required several admissions to hospital. Seven patients were still using the equipment at one year. The patients who were treated successfully used the machine for between six and 10 hours each (table 3) . The increase in total sleep time was due to an increase in both REM and non-REM sleep; there was no clinically significant change in the proportion of REM to non-REM sleep.
INVESTIGATIONS
Arterial blood gas tensions in the mid afternoon during spontaneous ventilation before the start of nasal intermittent positive pressure ventilation at six months and at one year are shown in figure 1 . The six month values in patients continuing to use the ventilator have been reported previously.4 At one year Pao2 was unchanged in the seven patients (median change compared with values before nasal 100% alveolar ventilation is probably the predominant mechanism of the improved gas tensions during sleep, other factors may be important. Nasal intermittent positive pressure ventilation may improve matching of ventilation and perfusion by reducing or preventing the fall in 50% functional residual capacity during sleep and 100 mm Hg causing re-expansion of atelectatic areas of lung. Leakage around the mask and through the mouth may reduce ventilation, particularly during sleep. We used commercially available 40 mm Hg masks, which come in various different sizes, and an adequate seal between the mask and the patient's face was obtained in all cases. The problem of leakage from the mouth was diminished by using a chin strap, but most patients 100% did not like this and had discarded it by the time of the follow up sleep study at six months. Leakage from the mouth was compensated for by using large minute volumes (median 23 (10-28) 1/min), which resulted in high inflation pressures of 30-40 cm H20 during wakeful-100 mm Hg ness; with the onset of sleep these fell to 20-30 cm H20 and blood gas tensions were successfully controlled. Additionally, patients were encouraged to have the inspiratory time as long as possible (median 1-3 s (0-8 to 1-6) and median inspiratory/expiratory ratio 1 :2-0 (1:17 40 mm Hg to 1:4-0)) to minimise peak inflation pressures on dioxide and promote gas exchange in diseased lung ermittent units with long time constants. middle of Improved quality of sleep was an important benefit of nasal intermittent positive pressure ventilation for the patients who continued noticeably treatment, and this was confirmed objectively sitivepres-by full polysomnography. Despite a night of itinuing to acclimatisation, they still experienced ase in total moderate sleep disruption in the laboratory, nt positive but in their own homes most reported sleeping h spontan-through the night or having only occasional Lt was not arousals. The usual reasons for waking were a night with dry throat or painful gastric distension. The as the in-sleep studies were not performed in a random .ofoxygen order as the study during nasal intermittent re reduced positive pressure ventilation always followed increased that during spontaneous breathing; the improvement in sleep duration during nasal intermittent positive pressure ventilation may therefore have been a consequence of familiarity with the sleep laboratory. However, a night of acclimatisation preceded the formal study on each occasion and the gap between the 2 NIPPV two studies was six months. humans,"1 acute hypercapnia with an increase in Paco2 of 6 to 15 mm Hg is a reliable and powerful arousal stimulus.'2 Therefore the improved sleep during nasal intermittent positive pressure ventilation may reflect the reduced Ptcco2, but other factors may also be important. The three patients who withdrew had difficulties sleeping with the equipment and had had relatively undisturbed sleep before starting positive pressure ventilation. Disturbed sleep during spontaneous breathing seems to be an important requirement for a successful outcome.
The previously reported improvements in Paco2 and bicarbonate ion concentration were maintained and, in most patients, improved further at one year. These differences might have been larger in cases 8 and 11 if the patients had not had a period of in hospital nasal intermittent positive pressure ventilation before being recruited to the study. These data suggest that the full benefit of domiciliary treatment develops over a relatively long period.
Although objective measurement of quality of life did not show significant changes, it was no worse during nasal intermittent positive pressure ventilation. Five oxygen was not seen until after 500 days of treatment had elapsed, the best predictor of death during this period being a combination of polycythaemia and hypercapnia. " In another study, in which benefit from long term oxygen therapy was apparent immediately, 29 out of 57 patients who were hypercapnic on entry died during the study compared with only 3 out of 15 who were normocapnic.'8 A reduction in hypercapnia may therefore improve survival. However Robert et al, giving patients with chronic obstructive lung disease positive pressure ventilation via a tracheostomy, found no difference in survival compared with the results in patients given oxygen in other studies.'9 The effect of noctumal ventilation on Paco2 was not recorded and a tracheostomy may be associated with a significant morbidity and mortality. 20 The improvements in oxygenation in our study during nasal intermittent positive pressure ventilation and during the day were less than those seen with long term oxygen therapy. The lower Pao2 may have an adverse effect on survival; although oxygen could be added through an integral port in the mask, this would add to the cost and complexity of home treatment.
Continuous positive airway pressure is cheaper and easier to administer than nasal intermittent positive pressure ventilation and was effective in controlling nocturnal desaturation in a patient with severe obesity hypoventilation syndrome.2' However, the effect on daytime or night time Paco2 was not evaluated, and when continuous positive airway pressure was used in patients with kyphoscoliosis during sleep it was ineffective in controlling hypercapnia, except in two patients with predominantly upper airway obstruction.2 Continuous positive airway pressure is therefore unlikely to be effective in patients with chronic obstructive lung disease unless they have predominantly upper airway obstruction.
Thus our study shows that nasal intermittent positive pressure ventilation can be used effectively in some patients with chronic obstructive lung disease but its further place in the management of chronic respiratory failure due to such disease can be determined only by a large scale randomised comparison with long term oxygen therapy. The 
